Zenas BioPharma, Inc.
ZBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $342 | $689 | $689 |
| - Cash | $320 | $57 | $67 |
| + Debt | $1 | $21 | $2 |
| Enterprise Value | $23 | $653 | $623 |
| Revenue | $5 | $50 | $0 |
| % Growth | -90% | – | – |
| Gross Profit | -$134 | $50 | -$62 |
| % Margin | -2,682.8% | 100% | – |
| EBITDA | -$164 | -$27 | -$75 |
| % Margin | -3,275% | -54.1% | – |
| Net Income | -$157 | -$37 | -$119 |
| % Margin | -3,139.8% | -74.2% | – |
| EPS Diluted | -3.76 | -0.97 | -3.11 |
| % Growth | -287.6% | 68.8% | – |
| Operating Cash Flow | -$120 | -$31 | -$66 |
| Capital Expenditures | -$0 | -$0 | -$2 |
| Free Cash Flow | -$120 | -$31 | -$68 |